EV Soloff, MM Al-Hawary, TS Desser… - American Journal of …, 2022 - Am Roentgen Ray Soc
Despite important innovations in the treatment of pancreatic ductal adenocarcinoma (PDAC), PDAC remains a disease with poor prognosis and high mortality. A key area for …
Objectives To develop a bounding-box-based 3D convolutional neural network (CNN) for user-guided volumetric pancreas ductal adenocarcinoma (PDA) segmentation. Methods …
LC Chu, EK Fishman - International journal of surgery, 2024 - journals.lww.com
Radiology plays an important role in the initial diagnosis and staging of patients with pancreatic ductal adenocarcinoma (PDAC). CT is the preferred modality over MRI due to …
TL de Jong, D Koopman, CAJ van der Worp… - Surgical Oncology, 2023 - Elsevier
Background We studied the added value of digital FDG-PET/CT in disease staging and restaging compared to the standard work-up with contrast enhanced CT (ceCT) and CA19-9 …
MA van Dam, FA Vuijk, JA Stibbe, RD Houvast… - Cancers, 2021 - mdpi.com
Simple Summary Patients diagnosed with pancreatic cancer have a poor prognosis at time of diagnosis, with a 5-year survival rate of merely 10%. The only treatment with curative …
TF Stoop, E van Veldhuisen, LB van Rijssen… - … Archives of Surgery, 2022 - Springer
Background Restaging of locally advanced pancreatic cancer (LAPC) after induction chemotherapy using contrast-enhanced computed tomography (CE-CT) imaging is …
C Qu, P Zeng, H Wang, C Yuan… - Journal of Magnetic …, 2022 - Wiley Online Library
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest malignant tumors of the human digestive system. Due to its insidious onset, many patients have already lost the …
LC Chu, ZJ Wang, A Kambadakone, EM Hecht… - Abdominal …, 2023 - Springer
Purpose Surgical resection is the only potential curative treatment for patients with pancreatic ductal adenocarcinoma (PDAC), but unfortunately most patients recur within 5 …
S Miyahara, H Takahashi, H Akita, K Sasaki… - Annals of Surgical …, 2024 - Springer
Background Appropriate re-evaluation after neoadjuvant treatment (NAT) is important for optimal treatment selection. Nonetheless, determining the operative eligibility of patients …